Twice-Yearly siRNA LDL Cholesterol Therapy: Trial Data and Supply Logistics for Indian Hospitals

Cholesterol-lowering injections are no longer all alike. Antibody PCSK9 inhibitors are given every two or four weeks. A newer class, small interfering RNA (siRNA), is given at much longer intervals. For hospital pharmacies, cardiology units and procurement teams in India, a six-monthly schedule changes how stock, recall and cold chain are planned. This article reports […]
Anabolic vs Antiresorptive Osteoporosis Therapy: What the Trials Report and How Hospitals Plan Supply in India

Osteoporosis medicines fall into two broad groups. Antiresorptive agents slow bone breakdown. Anabolic agents stimulate bone formation. For hospital pharmacies, clinics and procurement teams in India, the difference matters because the two groups differ in course length, storage and how they are sequenced. This article reports what published trials and reviews say, and what supply […]
Anaphylaxis Emergency Kit for Clinics and Hospitals: A Stocking Checklist

What published guidelines list for an anaphylaxis emergency kit: medicines, equipment, storage, expiry checks and reorder planning for clinics, hospitals and pharmacies in India.
Intra-Articular Hyaluronic Acid for Knee Osteoarthritis in India: What Labels and Guidelines Report
What published guidelines (OARSI, ACR/AF, AAOS, NICE) and product labels report on intra-articular hyaluronic acid for knee osteoarthritis, for hospital and pharmacy buyers in India.
Osimertinib 80 mg in India: Brands, Availability and Sourcing Guide for Hospitals (2026)

Osimertinib has become the reference treatment for EGFR-mutated non-small cell lung cancer (NSCLC), and hospital pharmacies, oncology centres and chemists across India now field the same questions again and again: which osimertinib 80 mg brands are in the market, how do they differ, and how can a buyer confirm that stock is genuine and correctly […]
Multiple Myeloma Treatment in India: What Anti-CD38 Antibody Trial Data and Labels Report

For hospital pharmacy committees, oncology and haematology units, clinics and pharmacies, anti-CD38 monoclonal antibodies are among the most frequently cited biologics in multiple myeloma. This article reports what prescribing information and published trials say about this class, written for institutional buyers and clinicians. It is informational reporting, not clinical guidance. What the Label Describes The […]
Seasonal Influenza Vaccination in India: What Labels and WHO Guidance Report for Hospital Programmes

What manufacturer labels, WHO advisories and Indian bodies report on seasonal quadrivalent influenza vaccines, for hospital and clinic procurement teams.
Neutropenia and G-CSF Therapy in India: What Labels and Guidelines Report

Granulocyte colony-stimulating factors (G-CSFs) such as filgrastim are used in oncology to address neutropenia, a low neutrophil count that raises the risk of serious infection during chemotherapy. Several items bear on how they are discussed: the American Society of Clinical Oncology (ASCO) published an updated guideline on white blood cell growth factors in 2026, the […]
Denosumab 60 mg vs 120 mg: What the Prolia and Xgeva Labels and Trials Report

Denosumab 60 mg vs 120 mg is a comparison hospital pharmacies run into often, because the same medicine is stocked in two very different forms under two different brand names. The 60 mg product (sold as Prolia) and the 120 mg product (sold as Xgeva) contain the same antibody, yet their approved uses, labelled schedules […]
Epinephrine Auto-Injectors in India: What the EpiPen Label and Anaphylaxis Guidance Report

Epinephrine (adrenaline) auto-injectors such as EpiPen and EpiPen Jr are single-dose, pre-filled devices that deliver a fixed dose of epinephrine into the outer thigh. Several recent items bear on how they are discussed: the US prescribing information for EpiPen and EpiPen Jr was revised in March 2026; an international expert panel published consensus recommendations on […]
